A detailed history of Stansberry Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Stansberry Asset Management, LLC holds 6,595 shares of LLY stock, worth $5.47 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
6,595
Previous 5,480 20.35%
Holding current value
$5.47 Million
Previous $4.26 Million 40.04%
% of portfolio
0.86%
Previous 0.63%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $808,230 - $1.01 Million
1,115 Added 20.35%
6,595 $5.97 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $3.25 Million - $4.34 Million
5,480 New
5,480 $4.26 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $788B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Stansberry Asset Management, LLC Portfolio

Follow Stansberry Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stansberry Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stansberry Asset Management, LLC with notifications on news.